<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7809375</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3455</journal-id>
<journal-id journal-id-type="nlm-ta">Dev Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Dev. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Developmental neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0378-5866</issn>
<issn pub-type="epub">1421-9859</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28490020</article-id>
<article-id pub-id-type="pmc">6447288</article-id>
<article-id pub-id-type="doi">10.1159/000471509</article-id>
<article-id pub-id-type="manuscript">NIHMS978247</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Williams</surname>
<given-names>Monica</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Zhi</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nance</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drewes</surname>
<given-names>Julia L.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lesniak</surname>
<given-names>Wojciech G.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Sarabdeep</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chugani</surname>
<given-names>Diane C.</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rangaramanujam</surname>
<given-names>Kannan</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Graham</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kannan</surname>
<given-names>Sujatha</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University SOM, Baltimore, MD</aff>
<aff id="A2"><label>b</label>Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University SOM, Baltimore, MD</aff>
<aff id="A3"><label>c</label>Department of Molecular and Comparative Pathobiology, Johns Hopkins University SOM, Baltimore, MD</aff>
<aff id="A4"><label>d</label>Nemours/AI duPont Hospital for Children, Wilmington, DE</aff>
<aff id="A5"><label>e</label>Communication Sciences and Disorders Department, College of Health Sciences, University of Delaware, Newark, DE, USA</aff>
<author-notes>
<corresp id="CR1">Dr. Sujatha Kannan, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Bloomberg Children's Center 6318D, 1800 Orleans Street, Baltimore, MD 21287 (USA), <email>skannan3@jhmi.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>39</volume>
<issue>5</issue>
<fpage>399</fpage>
<lpage>412</lpage>
<!--elocation-id from pubmed: 10.1159/000471509-->
<abstract id="ABS1">
<p id="P1">Maternal inflammation has been linked to neurodevelopmental and neuropsychiatric disorders such as cerebral palsy, schizophrenia, and autism. We had previously shown that intrauterine inflammation resulted in a decrease in serotonin, one of the tryptophan metabolites, and a decrease in serotonin fibers in the sensory cortex of newborns in a rabbit model of cerebral palsy. In this study, we hypothesized that maternal inflammation results in alterations in tryptophan pathway enzymes and metabolites in the placenta and fetal brain. We found that intrauterine endotoxin administration at gestational day 28 (G28) resulted in a significant upregulation of indoleamine 2,3-dioxygenase (IDO) in both the placenta and fetal brain at G29 (24 h after treatment). This endotoxin-mediated IDO induction was also associated with intense microglial activation, an increase in interferon gamma expression, and increases in kynurenine and the kynurenine pathway metabolites kynurenine acid and quinolinic acid, as well as a significant decrease in 5-hydroxyindole acetic acid (a precursor of serotonin) levels in the periventricular region of the fetal brain. These results indicate that maternal inflammation shunts tryptophan metabolism away from the serotonin to the kynurenine pathway, which may lead to excitotoxic injury along with impaired development of serotonin-mediated thalamocortical fibers in the newborn brain. These findings provide new targets for prevention and treatment of maternal inflammation-induced fetal and neonatal brain injury leading to neurodevelopmental disorders such as cerebral palsy and autism.</p>
</abstract>
<kwd-group>
<kwd>Maternal infection</kwd>
<kwd>Cerebral palsy</kwd>
<kwd>Microglia</kwd>
<kwd>Tryptophan</kwd>
<kwd>Kynurenine pathway</kwd>
<kwd>Serotonin</kwd>
<kwd>Autism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>